These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17537644)

  • 1. FGF2 effects in periosteal fibroblasts bearing the FGFR2 receptor Pro253 Arg mutation.
    Lilli C; Bellucci C; Baroni T; Aisa C; Carinci P; Scapoli L; Carinci F; Pezzetti F; Lumare E; Stabellini G; Bodo M
    Cytokine; 2007 Apr; 38(1):22-31. PubMed ID: 17537644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic fibroblast growth factor: effects on matrix remodeling, receptor expression, and transduction pathway in human periosteal fibroblasts with FGFR2 gene mutation.
    Bodo M; Lilli C; Aisa MC; Scapoli L; Bellucci C; Rinaldi E; Tosi L; Baroni T; Conte C; Bellocchio S; Carinci F; Stabellini G; Carinci P
    J Interferon Cytokine Res; 2002 Jun; 22(6):621-30. PubMed ID: 12162872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the extracellular matrix and growth factors in skull morphogenesis and in the pathogenesis of craniosynostosis.
    Carinci P; Becchetti E; Bodo M
    Int J Dev Biol; 2000; 44(6):715-23. PubMed ID: 11061436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation.
    Baroni T; Carinci P; Lilli C; Bellucci C; Aisa MC; Scapoli L; Volinia S; Carinci F; Pezzetti F; Calvitti M; Farina A; Conte C; Bodo M
    J Cell Physiol; 2005 Feb; 202(2):524-35. PubMed ID: 15389579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
    Britto JA; Moore RL; Evans RD; Hayward RD; Jones BM
    J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis.
    Yin L; Du X; Li C; Xu X; Chen Z; Su N; Zhao L; Qi H; Li F; Xue J; Yang J; Jin M; Deng C; Chen L
    Bone; 2008 Apr; 42(4):631-43. PubMed ID: 18242159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel molecular pathways elicited by mutant FGFR2 may account for brain abnormalities in Apert syndrome.
    Yeh E; Fanganiello RD; Sunaga DY; Zhou X; Holmes G; Rocha KM; Alonso N; Matushita H; Wang Y; Jabs EW; Passos-Bueno MR
    PLoS One; 2013; 8(4):e60439. PubMed ID: 23593218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiles of craniosynostosis-derived fibroblasts.
    Carinci F; Bodo M; Tosi L; Francioso F; Evangelisti R; Pezzetti F; Scapoli L; Martinelli M; Baroni T; Stabellini G; Carinci P; Bellucci C; Lilli C; Volinia S
    Mol Med; 2002 Oct; 8(10):638-44. PubMed ID: 12477974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
    Ang BU; Spivak RM; Nah HD; Kirschner RE
    J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apert p.Ser252Trp mutation in FGFR2 alters osteogenic potential and gene expression of cranial periosteal cells.
    Fanganiello RD; Sertié AL; Reis EM; Yeh E; Oliveira NA; Bueno DF; Kerkis I; Alonso N; Cavalheiro S; Matsushita H; Freitas R; Verjovski-Almeida S; Passos-Bueno MR
    Mol Med; 2007; 13(7-8):422-42. PubMed ID: 17622301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand.
    Anderson J; Burns HD; Enriquez-Harris P; Wilkie AO; Heath JK
    Hum Mol Genet; 1998 Sep; 7(9):1475-83. PubMed ID: 9700203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence analysis of fibroblast growth factor receptor 2 ( FGFR2 ) in Japanese patients with craniosynostosis.
    Sakai N; Tokunaga K; Yamazaki Y; Shida H; Sakata Y; Susami T; Nakakita N; Takato T; Uchinuma E
    J Craniofac Surg; 2001 Nov; 12(6):580-5. PubMed ID: 11711827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apert and Crouzon syndromes: clinical findings, genes and extracellular matrix.
    Carinci F; Pezzetti F; Locci P; Becchetti E; Carls F; Avantaggiato A; Becchetti A; Carinci P; Baroni T; Bodo M
    J Craniofac Surg; 2005 May; 16(3):361-8. PubMed ID: 15915098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicogenetic study of Turkish patients with syndromic craniosynostosis and literature review.
    Nur BG; Pehlivanoğlu S; Mıhçı E; Calışkan M; Demir D; Alper OM; Kayserili H; Lüleci G
    Pediatr Neurol; 2014 May; 50(5):482-90. PubMed ID: 24656465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A regulatory role of fibroblast growth factor in the expression of decorin, biglycan, betaglycan and syndecan in osteoblasts from patients with Crouzon's syndrome.
    Bodo M; Baroni T; Carinci F; Becchetti E; Bellucci C; Conte C; Pezzetti F; Evangelisti R; Tognon M; Carinci P
    Eur J Cell Biol; 1999 May; 78(5):323-30. PubMed ID: 10384983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of a novel FGFR2 mutation, E731K, in craniosynostosis.
    Park J; Park OJ; Yoon WJ; Kim HJ; Choi KY; Cho TJ; Ryoo HM
    J Cell Biochem; 2012 Feb; 113(2):457-64. PubMed ID: 21928350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of nanogel-based delivery of soluble FGFR2 with S252W mutation on craniosynostosis.
    Yokota M; Kobayashi Y; Morita J; Suzuki H; Hashimoto Y; Sasaki Y; Akiyoshi K; Moriyama K
    PLoS One; 2014; 9(7):e101693. PubMed ID: 25003957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crouzon's syndrome: differential in vitro secretion of bFGF, TGFbeta I isoforms and extracellular matrix macromolecules in patients with FGFR2 gene mutation.
    Baroni T; Lilli C; Marinucci L; Bellocchio S; Pezzetti F; Carinci F; Stabellini G; Balducci C; Locci P
    Cytokine; 2002 Jul; 19(2):94-101. PubMed ID: 12182844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
    Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
    Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR2 mutations among Thai children with Crouzon and Apert syndromes.
    Shotelersuk V; Mahatumarat C; Ittiwut C; Rojvachiranonda N; Srivuthana S; Wacharasindhu S; Tongkobpetch S
    J Craniofac Surg; 2003 Jan; 14(1):101-4; discussion 105-7. PubMed ID: 12544231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.